Careers Contact
Careers Contact

Investors

Since 2021, Evaxion has been listed on the Nasdaq Capital Market exchange (ticker code: EVAX). Here you can find all of the latest Evaxion investor insights: our results, upcoming events and news, important shareholder updates and much more.

Latest press releases

Email alerts
View all
Apr 17, 2026

Evaxion’s AI-Immunology™ platform demonstrates 86% vaccine target precision in phase 2 personalized cancer vaccine trial
Apr 17, 2026

New data demonstrates the unique scalability of Evaxion’s AI-Immunology™ platform in glioblastoma
Apr 16, 2026

Evaxion concludes Annual General Meeting

Upcoming events & presentations

View all
Apr 22, 2026
|
04:50 PM
|
Copenhagen, Denmark
Økonomisk Ugebrev Life Science Investor Conference
Evaxion will participate in the Life Science Investor Conference on April 22, 2026, in Copenhagen. The event brings together a selection of Nordic life science companies to present their latest developments, results, and future plans to investors and other stakeholders. The event takes place at Symbion, Room K1, Fruebjergvej 3, 2100 Copenhagen Ø, from 13:30 […]
Learn more

Latest events & presentations

View all
Apr 17 – Apr 22, 2026
|
San Diego, United States
AACR Annual Meeting 2026
The AACR Annual Meeting is the focal point of the cancer research community, where scientists, clinicians, other health care professionals, survivors, patients, and advocates gather to share the latest advances in cancer science and medicine. From population science and prevention; to cancer biology, translational, and clinical studies; to survivorship and advocacy; the AACR Annual Meeting highlights the work of the best minds in cancer research from institutions all over the world.
Learn more
Q4

Latest quarterly report

View all financial reports
Presentation Presentation Webcast Webcast Transcript Transcript Press release Press release SEC filing SEC filing

Contact IR

Mads Kronborg
Vice President, Investor Relations & Communication
Email: mak@evaxion.ai
Telephone: +45 53 54 82 96

Company presentation

Stay in touch

LinkedIn
Follow Evaxion on LinkedIn to engage, connect, and stay informed.
Follow us
Twitter
Join the conversation and stay updated with Evaxion on X.
Follow us
Subscribe to email news alerts
Join our mailing list to get our latest press releases delivered straight to your inbox.
Sign up